$ENTB - Entest Biomedical, Inc. (OTCMKTS: ENTB) is a company that focuses on the development and commercialization of immunotherapeutic therapies for the veterinary market in the United States. Between 15 million and 20 million dogs are currently kept as pets in the United States. That’s a huge potential market.
(0)
(0)